Subscribe To
Io biotech to present at the jefferies healthcare conference
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...
May 30, 2023, 4:35 pm
Tech, pharma stocks lead european equities sharply lower in tuesday trading
Tech and pharmaceutical stocks led European equities sharply lower in Tuesday trading as American depos...
May 30, 2023, 3:29 pm
Regeneron pharmaceuticals, inc. (regn) td cowen 4th annual oncology innovation summit (transcript)
Regeneron pharmaceuticals, Inc. (NASDAQ:REGN ) TD Cowen 4th Annual Oncology Innovation Summit May 30, 2...
May 30, 2023, 3:18 pm
Why shares of taro pharmaceutical are rising tuesday
Taro saw rising revenue in the fourth quarter but falling net income. Sun pharmaceutical already owns 7...
May 30, 2023, 12:25 pm
Bionomics announces upcoming poster presentation at the american society of clinical psychopharmacology (ascp) annual meeting
ADELAIDE, Australia and CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clin...
May 30, 2023, 10:00 am
Amylyx says european drug regulator likely to reject als drug
Amylyx pharmaceuticals Inc said on Tuesday the European drug regulator was likely to reject its amyotro...
May 30, 2023, 8:43 am
Harmony biosciences to participate in goldman sachs 44th annual global healthcare conference
PLYMOUTH MEETING, Pa. , May 30, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a ...
May 30, 2023, 8:05 am
Vertex to participate in the goldman sachs 44th annual global healthcare conference on june 13
BOSTON--(BUSINESS WIRE)--Vertex pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management ...
May 30, 2023, 8:01 am
Eyepoint pharmaceuticals: a puncher's chance for long acting eye disease drug success
EyePoint is a $200m market cap biotech focused on eye disease. The company's long-acting Durasert technology has been supporting its commercial produc...
May 30, 2023, 8:00 am
Medivir to present at the abgsc life science summit
STOCKHOLM , May 30, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company ...
May 30, 2023, 3:22 am
Mgc pharmaceuticals announces boardroom changes, reflecting its shift of focus
MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC), a specialist in plant-inspired medicines, has a...
May 30, 2023, 3:02 am
Global mannitol market is expected to reach a revenue of us$ 890.31 million, rising at a cagr of 7.1% by 2033 end | data analysis by future market insights inc.
Mannitol Market Sales Rising As Consumption within Food & Beverage and pharmaceutical Industry Surges. ...
May 30, 2023, 1:30 am
Madrigal: setting the pace in the nash market (rating upgrade)
Madrigal pharmaceuticals' drug, resmetirom, for non-alcoholic fatty liver diseases, received FDA's Brea...
May 30, 2023, 1:19 am
Specialty enzymes market size worth usd 3.27 billion by 2032 at 6.82% cagr – report by market research future (mrfr)
Specialty Enzymes Market Trends and Insights By Source (Plants, Microorganisms, Animal), By Application (pharm...
May 29, 2023, 2:35 pm
Pallets market is estimated to reach a valuation of us$ 11,222.6 million at a moderate cagr of 5.8% by forecast period of 2033 end | future market insights, inc.
The pharmaceutical industry’s increasing need for pallets is projected to make the United States a hi...
May 29, 2023, 11:30 am
Pfizer: not quite dead money walking
PFE's historical stock performance remains mediocre compared to its pharmaceutical peers, even after ad...
May 29, 2023, 9:00 am
Recursion pharmaceuticals is going big on ai. here's why it could be worth buying
Recursion pharmaceuticals just acquired a pair of AI-related biotechs. This could bolster its drug disc...
May 29, 2023, 8:45 am
Avicanna finalizes deal to acquire medical cannabis by shoppers business
Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) told investors it has executed a definitive asset purchase agreement with Shoppers Drug Mart to acquire the asse...
May 29, 2023, 8:27 am
Ultragenyx: a promising bet on rare genetic disorder therapies
Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701, offering transformative potential...
May 29, 2023, 7:15 am
Verona pharma: poised for a breakthrough in copd treatment amidst favorable financial position
Verona Pharma, a clinical-stage biopharmaceutical company, is making strides with its novel COPD treatm...
May 28, 2023, 9:08 am